Source: FierceBiotech

MolecularMD: Icon snaps up molecular DX specialist MolecularMD for undisclosed price

Icon, a CRO based in Dublin, acquired MolecularMD, a molecular diagnostic specialty lab that focuses on a platform for the development and commercialization of precision medicines for oncology.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Dan Snyder's photo - President & CEO of MolecularMD

President & CEO

Dan Snyder

CEO Approval Rating

79/100

Read more